Amulet Capital Partners

US Fertility is a physician-owned and physician-led top-tier fertility practice with a shared mission to drive innovation and leverage best practices to improve patient experience and treatment outcomes. Their combined clinical and operational expertise provides advanced business and digital solutions to their fertility partner practices, streamlining and improving the delivery of exceptional patient care.

SSI Strategy operates as a life sciences consultancy. SSI Strategy combines business acumen, medical, clinical, and pharmacovigilance domain expertise, and operating experience to provide unparalleled support to our clients.

SSI Strategy operates as a life sciences consultancy. SSI Strategy combines business acumen, medical, clinical, and pharmacovigilance domain expertise, and operating experience to provide unparalleled support to our clients.

OPEN Health is a healthcare communications and market access agency that provides a range of services to the pharmaceutical and life sciences sectors. Founded in 2011 and headquartered in Chicago, Illinois, with offices in the United Kingdom, the Netherlands, Germany, India, and China, the company specializes in consulting, digital marketing communications, medical education, public relations, and data consultancy. OPEN Health also offers expertise in market access strategy, health economic modeling, real-world evidence, patient engagement, and scientific communications. With a workforce of around 200 professionals, the agency collaborates with numerous top pharmaceutical companies, as well as various healthcare organizations, from startups to multinational corporations, delivering tailored solutions on both regional and global scales.

Children’s Choice providing access to quality engaging care to children.

Peloton Advantage, LLC is a privately owned medical communications company specializing in strategic publication planning and associated content development for medical education programs. While establishing their industry leadership position over the last twelve years, we have received several awards for our successful growth from Inc., New Jersey Business, NJBIZ, and SmartCEO magazines and now employ more than 80 of the top professionals in medical communications. Their teams support US and global accounts for large and small pharmaceutical, biotechnology, and medical device companies, contributing to the success of more than 90 products spanning all major therapeutic areas.

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With our “Shared Work – Shared Vision” philosophy we provide customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, we deliver trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications.